EKSO vs. ASYS, TPIC, KITT, SHMD, FTEK, TRSG, GTEC, LBGJ, TRT, and CVV
Should you be buying Ekso Bionics stock or one of its competitors? The main competitors of Ekso Bionics include Amtech Systems (ASYS), TPI Composites (TPIC), Nauticus Robotics (KITT), SCHMID Group (SHMD), Fuel Tech (FTEK), Tungray Technologies (TRSG), Greenland Technologies (GTEC), Li Bang International (LBGJ), Trio-Tech International (TRT), and CVD Equipment (CVV). These companies are all part of the "machinery" industry.
Ekso Bionics vs.
Ekso Bionics (NASDAQ:EKSO) and Amtech Systems (NASDAQ:ASYS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, community ranking, media sentiment and valuation.
6.4% of Ekso Bionics shares are held by institutional investors. Comparatively, 50.2% of Amtech Systems shares are held by institutional investors. 6.0% of Ekso Bionics shares are held by company insiders. Comparatively, 8.0% of Amtech Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Ekso Bionics presently has a consensus price target of $2.50, indicating a potential upside of 760.29%. Given Ekso Bionics' stronger consensus rating and higher probable upside, research analysts plainly believe Ekso Bionics is more favorable than Amtech Systems.
Amtech Systems has a net margin of 1.18% compared to Ekso Bionics' net margin of -62.95%. Amtech Systems' return on equity of 0.66% beat Ekso Bionics' return on equity.
In the previous week, Ekso Bionics and Ekso Bionics both had 7 articles in the media. Amtech Systems' average media sentiment score of 0.73 beat Ekso Bionics' score of 0.21 indicating that Amtech Systems is being referred to more favorably in the news media.
Amtech Systems has higher revenue and earnings than Ekso Bionics. Amtech Systems is trading at a lower price-to-earnings ratio than Ekso Bionics, indicating that it is currently the more affordable of the two stocks.
Ekso Bionics received 24 more outperform votes than Amtech Systems when rated by MarketBeat users. However, 58.98% of users gave Amtech Systems an outperform vote while only 53.97% of users gave Ekso Bionics an outperform vote.
Ekso Bionics has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500. Comparatively, Amtech Systems has a beta of 1.53, meaning that its share price is 53% more volatile than the S&P 500.
Summary
Amtech Systems beats Ekso Bionics on 12 of the 17 factors compared between the two stocks.
Get Ekso Bionics News Delivered to You Automatically
Sign up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Ekso Bionics Competitors List
Related Companies and Tools
This page (NASDAQ:EKSO) was last updated on 5/21/2025 by MarketBeat.com Staff
Buy EKSO Stock Free EKSO Stock Alerts